SCHEMBL8285204

SCHEMBL8285204

Cc1nc2c(cc1/C=C/C(N)=O)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 6/20 0.38
HDAC8 Q9BY41 6/20 0.38
HDAC6 Q9UBN7 6/20 0.38
HDAC10 Q969S8 3/20 0.38
HDAC2 Q92769 2/20 0.38
HDAC11 Q96DB2 2/20 0.38
PDE11A Q9HCR9 1/20 0.37
EGFR P00533 1/20 0.36
BTK Q06187 1/20 0.36
PDE4A P27815 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
HDAC3 O15379 1/20 0.35
APP P05067 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC9 Q9UKV0 1/20 0.35
HDAC5 Q9UQL6 1/20 0.35
GSK3B P49841 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5871748 0.92 HDAC1 (0.39) HDAC1HDAC8HDAC6HDAC10HDAC2
SCHEMBL5871760 0.92 HDAC1 (0.39) HDAC1HDAC8HDAC6HDAC10HDAC2
SCHEMBL8285212 0.91 HDAC1 (0.40) HDAC1HDAC8HDAC6HDAC10HDAC2
SCHEMBL8287362 0.89 HDAC1 (0.41) HDAC1HDAC8HDAC6HDAC10HDAC2
SCHEMBL5872140 0.89 HDAC1 (0.37) HDAC1HDAC8HDAC6HDAC10HDAC2
SCHEMBL5872137 0.89 HDAC1 (0.37) HDAC1HDAC8HDAC6HDAC10HDAC2
SCHEMBL8287126 0.88 HDAC1 (0.37) HDAC1HDAC8HDAC6HDAC10HDAC2
SCHEMBL8285201 0.85 LMNA (0.40) HDAC1HDAC8HDAC6HDAC10HDAC2
SCHEMBL8285237 0.81 ALDH1A1 (0.41) PDE11APDE4APDE4BPDE4CPDE4D
SCHEMBL8287456 0.81 PDE11A (0.42) PDE11AGSK3BGAAHPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed